Mon. 15 Apr 2024, 7:22am ET
Benzinga
Earnings, Earnings Beats, News
Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.77) by 63.64 percent. This is a 46.15 percent increase over losses of $(0.52) per share from the same period last year.